LOADING
Comparing Mastercard Inc (MA) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $465.4B | $618.6B |
| P/E Ratio | 30.5 | 29.8 |
| Forward P/E | 26.9 | 22.2 |
| PEG Ratio | 1.62 | 4.94 |
| EPS | $17.28 | $8.63 |
| Revenue Growth (YoY) | 15.8% | 9.9% |
| Profit Margin | 45.9% | 21.8% |
| Return on Equity | 232.1% | 26.4% |
| Dividend Yield | 0.62% | 2.01% |
| Beta | 0.73 | 0.23 |
| 52-Week High | $598.04 | $269.43 |
| 52-Week Low | $463.74 | $151.01 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.